UK markets close in 2 hours 25 minutes

AnaptysBio, Inc. (0HFQ.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
29.75+1.10 (+3.86%)
As of 07:11PM GMT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -0.02
52-week change 3N/A
S&P500 52-week change 3-15.72%
52-week high 30.00
52-week low 30.00
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.75M
Implied shares outstanding 6N/A
Float 814.2M
% held by insiders 10.31%
% held by institutions 1117.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022


Profit margin 0.00%
Operating margin (ttm)-2,608.86%

Management effectiveness

Return on assets (ttm)-14.04%
Return on equity (ttm)-40.79%

Income statement

Revenue (ttm)4.49M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)-93.80%
Gross profit (ttm)-35.32M
EBITDA -116.48M
Net income avi to common (ttm)-134.85M
Diluted EPS (ttm)-2.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)442.97M
Total cash per share (mrq)15.58
Total debt (mrq)19.84M
Total debt/equity (mrq)7.15
Current ratio (mrq)21.39
Book value per share (mrq)9.79

Cash flow statement

Operating cash flow (ttm)-88.21M
Levered free cash flow (ttm)-53.32M